Pharmaceutical Care and Quality of Life in Conditions Related to Psychotropic Drug Use
NCT ID: NCT06889636
Last Updated: 2025-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
97 participants
INTERVENTIONAL
2021-12-01
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of the study are:
1. Side-effects are the most common DRPs in subjects using psychotropic medicines in primary care,
2. Treatment effectiveness and safety affect the subjects´ QoL
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychotropic Drug Use in the Elderly Living in Nursing Homes and the Influence of a Structured Drug Review
NCT03736577
Pharmacist-led Medication Review With Follow-up on Primary Care Cardiovascular Older Adult Patients.
NCT03502109
Daily Delivery and Supervision of Psychotropic Medication for High-Risk Patients With Severe/Persistent Mental Illness
NCT03766503
OPTImization of Medication by Transdisciplinary Assessment of Drug Treatment in Elderly Hospitalized Patients
NCT05387096
Polypharmacy Outpatient Clinic
NCT03911934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. assess QoL in subjects using psycholeptics and psychoanaleptics,
2. analyze identified DRPs and their causes in subjects using psycholeptics and psychoanaleptics
3. evaluate the correlation between the type and total number of DRPs identified in a single subject with QoL,
4. describe the impact of pharmacists´ intervention in the identification and resolution of the DRPs and their causes on subjects´ QoL.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standardized pharmaceutical care
Participants in group A received pharmacists' interventions based on standardized Medication Review (MR) and Medication Therapy Management (MTM) protocols.
Pharmaceutical care in solving drug-related problems in subjects using psychotropic medicines based on standardized protocol..
Pharmacists' interventions were based on Medication Review and Medication Therapy Management evaluations of a subjects' pharmacotherapy to optimize medicine use, improve treatment outcomes and quality of life. The intervention involved the identification of drug-related problems and addressing these issues through pharmacist interventions. The intervention was based on information gathered from the subjects and a list of medicines in use.
Basic counseling
Participants enrolled in group B received pharmaceutical care based on common pharmacist´s practice in Croatia.
Common pharmacists' practice in Croatia.
Group B participants received pharmaceutical care based on common pharmacists' practice in Croatia during the dispensing of psychotropic drugs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmaceutical care in solving drug-related problems in subjects using psychotropic medicines based on standardized protocol..
Pharmacists' interventions were based on Medication Review and Medication Therapy Management evaluations of a subjects' pharmacotherapy to optimize medicine use, improve treatment outcomes and quality of life. The intervention involved the identification of drug-related problems and addressing these issues through pharmacist interventions. The intervention was based on information gathered from the subjects and a list of medicines in use.
Common pharmacists' practice in Croatia.
Group B participants received pharmaceutical care based on common pharmacists' practice in Croatia during the dispensing of psychotropic drugs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Usage of psycholeptic or psychoanaleptic medicines
* Residence in Istrian County (Croatia)
Exclusion Criteria
* Hospitalization during study participation
* Unable to live by themselves
* Unable to participate in study for 3 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rijeka
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alena Tatarevic
Assessment of the impact of pharmaceutical care on the quality of life in conditions related to psychotropic drug use and evaluation of the intervention
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pharmacy Bobanovic Vujnovic Pula
Pula, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200-07/2023-01/1_001/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.